Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Forodesine in B-Cell Acute Lymphoblastic Leukemia
NCT00289562Phase 2Completed
- Sponsor
- BioCryst Pharmaceuticals, Inc.
- Start
- Sep 2004
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of forodesine in B cell acute lymphoblastic leukemia (B-ALL), sponsored by BioCryst Pharmaceuticals, Inc.. Started Sep 2004; status: completed.
02
Drugs
forodesine
03
Conditions
B cell acute lymphoblastic leukemia (B-ALL)
Beyond the preview
Go deeper on NCT00289562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00289562.